Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus Academic Article uri icon

Overview

MeSH Major

  • Electroencephalography
  • Midazolam
  • Monitoring, Physiologic
  • Status Epilepticus

abstract

  • Although most patients with RSE initially responded to cIV-MDZ, over half developed subsequent breakthrough seizures, which were predictive of post-treatment seizures and were often detectable only with cEEG. Titrating cIV-MDZ to burst suppression, more aggressive treatment with concurrent AED, or a longer period of initial treatment may reduce the high proportion of patients with RSE who relapse after cIV-MDZ is discontinued.

publication date

  • September 25, 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11571331

Additional Document Info

start page

  • 1036

end page

  • 42

volume

  • 57

number

  • 6